DavidGlennKochMDMSCR

Hepatology & Liver Transplantation

Hepatology Section Chief GI Fellowship Associate Program Director of Research Professor, Medicine, Medical University of South Carolina College of Medicine

Join to view full profile

Dr. Koch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Koch's full profile

Already have an account?

Office
25 Courtenay Dr
Charleston, SC 29425
Phone+1 843-792-6982

Education & Training

Medical University of South CarolinaFellowship, Gastroenterology, 2004 - 2007
University of Alabama Medical CenterResidency, Internal Medicine, 2001 - 2004
Louisiana State University School of Medicine in New OrleansClass of 2001

Certifications & Licensure

ME State Medical License 2020 - 2025
SC State Medical License 2004 - 2025
AL State Medical License 2002 - 2004
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury Start of enrollment: 2012 Jun 01
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Objective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Andrew D Schreiner, Jingwen Zhang, William P Moran, David G Koch, Justin Marsden
Endocrine Practice. 2024-11-01
FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.
Andrew D Schreiner, Jingwen Zhang, William P Moran, David G Koch, Justin Marsden
Journal of Clinical Gastroenterology. 2024-10-01
H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.
David G Koch, Don C Rockey, Sheldon S Litwin, Ryan J Tedford
Digestive Diseases and Sciences. 2024-08-01

Journal Articles

Use of Intra‐Aortic Counterpulsation in Cardiogenic Shock Post‐Liver Transplantation
Gabriel R Chedister, William D Stoll, Kenneth D Chavin, John W McGillicuddy, Satish N Nadig, David G Koch, Clinical Transplantation

Press Mentions

First Edition: April 23, 2020April 23rd, 2020

Grant Support

Novel Mechanisms of Hepatopulmonary SyndromeNIH/NHLBI2018–2024
TARGET-HCC: A Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular CarcinomaTARGET-RWE2016–2024
TARGET-NASH: A 5-year, Longitudinal, Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisTARGET-RWE2016–2024